propentofylline has been researched along with ubiquinone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuji, K; Hasegawa, T; Kameyama, T; Nabeshima, T; Nitta, A | 1 |
| Fuji, K; Furukawa, Y; Hasegawa, T; Hayashi, K; Hiramatsu, M; Kameyama, T; Nabeshima, T; Nitta, A; Yamada, K | 1 |
1 review(s) available for propentofylline and ubiquinone
| Article | Year |
|---|---|
Orally active NGF synthesis stimulators: potential therapeutic agents in Alzheimer's disease.
Topics: Alzheimer Disease; Animals; Benzoquinones; Humans; Nerve Growth Factors; Nootropic Agents; Rats; Ubiquinone; Xanthines | 1997 |
1 other study(ies) available for propentofylline and ubiquinone
| Article | Year |
|---|---|
Oral administration of NGF synthesis stimulators recovers reduced brain NGF content in aged rats and cognitive dysfunction in basal-forebrain-lesioned rats.
Topics: Administration, Oral; Aging; Analysis of Variance; Animals; Benzoquinones; Brain; Choline O-Acetyltransferase; Cognition; Humans; Learning; Male; Memory; Nerve Growth Factors; Rats; Rats, Wistar; Ubiquinone; Xanthines | 1994 |